BE study design issue [Design Issues]

posted by jag009  – NJ, 2019-12-13 22:26  – Posting: # 20973
Views: 756

Hi everyone,

Question, if one conducted a study comparing ER to an immediate release reference but not following the recommended dosage regimen of the IR. Example, as per product monograph IR is given every 4 hrs and the new ER is given every 8 hrs, but the guy designed the pk study comparing ER vs 2xIR with both give at time 0, The design is obviously wrong (due to IR dosing regimen) but would a regulatory body reject the study (assume the study pass the BE objective which is BE needed only for auc). A pivotal study not pilot.

PS, not me! Doing some due diligence..
Thx
J

Complete thread:

Activity
 Admin contact
20,236 posts in 4,258 threads, 1,396 registered users;
online 9 (0 registered, 9 guests [including 8 identified bots]).
Forum time (Europe/Vienna): 19:41 UTC

You can do one of two things; just shut up,
which is something I don’t find easy,
or learn an awful lot very fast,
which is what I tried to do.    Jane Fonda

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5